company tower banner
PLT Health Solutions Company Logo
Synapsa™ Natural Memory Support is a patented, standardized extract of Bacopa monnieri that has been shown to improve in- formation processing, enhance memory and upgrade intellectual performance - naturally and safely - in healthy adults. With exciting studies on this engaged demographic and more on the way - Synapsa is an ingredient that can help you build your brands in the categories of learning, memory and mental performance.

Ingredient Name: Bacopa Monnieri

Labeling Claims: GMO-free, Gluten-free, Halal, Kosher

Certifications & Compliance: Halal, Kosher

Technical Data Sheet
  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Ingredient Name
Ingredients
Bacopa Monnieri
Technologies

Features & Benefits

Product Highlights

In the United States today, millions of consumers are part of an information era that asks all of us to learn faster, remember more and process faster and more accurately in cognitively demanding environments. In college, at work or in the pursuit of a fuller, more rewarding life, there's a growing demand for 'peak cognitive performance'. It is safe, natural support for healthy adults who want 'peak cognitive performance'.

Potential Consumer Benefits
  • Faster information processing
  • Improved learning rate
  • Decreased forgetting rate
  • Improved memory consolidation
  • Better multitasking accuracy

Applications & Uses

Regulatory & Compliance

Certifications & Compliance

Technical Details & Test Data

On-Going Research Program

The unique composition of Synapsa has been studied in a range of high quality clinical
trials for over a decade. While most trials have shown performance improvement after
weeks of use, new data also suggest that even short term use of Synapsa can improve
mental performance. A fully-supported ongoing clinical research program promises
additional new data in the near future.

Visual processing, learning rate & memory consolidation (Stough, 2001): A randomized, double-blind, placebo-controlled 12-week study of 46 healthy adults, ages 18-60, showed a statistically significant improvement in speed of visual information processing, learning rate and memory consolidation in subjects consuming 300 mg/day Synapsa. A statistically significant reduction in the rate of forgetting was also observed.

Information retention (Roodenrys, 2002): A randomized, double-blind, placebo-controlled 12-week trial on a group of 76 adults, ages 40-65, demonstrated a significant effect of Synapsa on the retention of new information.

Working memory, visual info processing, improved accuracy (Stough, 2008): A randomized double-blind, placebo-controlled 90-day study with 62 participants, ages 18-60, consuming 300 mg/day Synapsa showed a statistically significant improvement in working memory, visual information processing (sustained attention) and accuracy in complex cognitive tasks.

Synapsa® - On-Going Research Program

The CDR computerized cognitive assessment battery was used to assess five cognitive factors at baseline and after the 90 d treat- ment period. Change from baseline Working Memory Score was significantly improved (p=0.035) in the Synapsa group. Work- ing Memory refers to a process in the brain that provides tempo- rary storage and manipulation of the information necessary for complex cognitive tasks such as language comprehension, learning, and reasoning.

Improved performance on demanding cognitive tests (Downey, 2012) (acute): Two different doses (320 mg/640 mg) were examined in this study on sustained cognitive performance, examining the acute (short term) effect of Synapsa in healthy adult subjects. Significantly improved performance was seen in faster information processing and improved decision making time, in a multitasking environment.